Labiotech.eu

News and Trends 9 Mar 2023

Ampersand Biomedicines launched to develop drugs that only work at disease sites

Flagship Pioneering has created Ampersand Biomedicines, a company creating programmable medicines that are intended to be safer, more tolerable, and effective by acting at the site of disease. Flagship Pioneering has initially committed $50 million to advance the company’s Address, Navigate, Design (AND) platform and develop an initial pipeline of medicines across a range of […]

March 9, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 9 Mar 2023

Beyond Biotech podcast 37: Natural killer cells, biopharma revenue, toxic shock syndrome vaccine

This week our guests are Marit Inngjerdingen from the Institute of Clinical Medicine in Norway; Kyle Forcier, senior director of life sciences product marketing at Model N; and Dr. Andreas Roetzer, head of R&D for vaccines at Biomedical Research & Bio-Products. The next breakthrough in cancer treatment? In our body, we have an innate immune […]

March 9, 2023

Best in Biotech 9 Mar 2023

5 advancements in kidney disease research over the past year

Prevalent in millions of people across the globe, kidney diseases manifest through various symptoms like blood and excess protein in urine, fluid retention causing swollen ankles, poor appetite and even the inability of the body to filter waste, resulting in acute kidney failure. To boost the research and development of treatments for kidney diseases, Kidney […]

March 9, 2023 - 7 minutesmins - By Roohi Mariam Peter

BIO-Europe Spring, Element Materials Technology, Ergomed, Rentschler Biosciences

Pharma services companies you should know about at Bio-Europe Spring 2023

Bio-Europe Spring 2023, which takes place March 20-22 in Basel, Switzerland, is the largest gathering of biopharma professionals in Europe. It presents an opportunity for companies from around the world to engage in face-to-face meetings and facilitate partnerships. Alongside networking, there will also be workshops, panels, exhibitions, and a variety of company presentations. The keynote […]

March 9, 2023 - 5 minutesmins - By Willow Shah-Neville

News and Trends 8 Mar 2023

Research looks to make drug appear like brain tumor ‘food’

New research has shown that the blood vessels that feed aggressive brain tumors have receptors that could allow a new type of drug-containing nanoparticle to be used to starve the tumors of the energy they use to grow and spread, and also cause other disruptions to their adapted existence, even killing themselves. Scientists from the […]

March 8, 2023 - 6 minutesmins - By Jim Cornall

News and Trends 8 Mar 2023

Affibody and Chiesi Group to develop treatments for respiratory diseases

Affibody AB and Chiesi Farmaceutici S.p.A have announced a collaboration and licensing agreement to develop and commercialize innovative treatments for respiratory diseases using Affibody’s proprietary technology. Under the terms of the agreement, the parties will collaborate to progress up to three programs based on Affibody molecules against undisclosed targets for respiratory diseases. Chiesi will fund […]

March 8, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 8 Mar 2023

Noema Pharma raises $112 million in Series B financing

Noema Pharma, a Swiss clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders, has closed an oversubscribed Series B financing round, raising CHF 103 million ($112 million) from new and existing investors. The round was co-led by leading European healthcare focused investment firms Forbion and Jeito Capital. UPMC Enterprises and an additional new investor […]

March 8, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 8 Mar 2023

Could changing mRNA provide a new target for Alzheimer’s disease?

Reducing the methylation of a key messenger RNA can promote migration of macrophages into the brain and ameliorate symptoms of Alzheimer’s disease in a mouse model. This is according to a new study in the open access journal PLOS Biology by Rui Zhang of Air Force Medical University in Xian, Shaanxi, China. The results highlight […]

March 8, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 8 Mar 2023

New bone cancer drug could save children’s lives

Researchers at the University of East Anglia (UEA) in the U.K. have developed a new drug that works against all of the main types of primary bone cancer. Cancer that starts in the bones, rather than cancer that has spread to the bones, predominantly affects children. Current treatments are grueling, with outdated chemotherapy cocktails and […]

March 8, 2023 - 4 minutesmins - By Jim Cornall

Opinion 8 Mar 2023

Should pharma be listening to social media to drive drug development?

By Thierry Escudier, consultant and strategic leader at The Pistoia Alliance The move towards patient centricity is gathering momentum, and digital technology is playing a huge role in this shift. Decentralized clinical trials that employ mobile apps and wearable devices to monitor patients and make results gathering easier are a particularly successful example of how […]

March 8, 2023 - 5 minutesmins - By External Contributor

News and Trends 8 Mar 2023

How to promote diversity in STEM

Leaders from OMass Therapeutics, SiSaf and Brainomix explain how to promote diversity in science, technology, engineering and math (STEM). OMass Therapeutics is a female-led business with diversity at its core. It was founded by the pioneering scientist and Oxford Professor Dame Carol Robinson and is led by the experienced biotech and pharma executive Ros Deegan. […]

March 8, 2023 - 6 minutesmins - By Jim Cornall

Best in Biotech 8 Mar 2023

5 women leading the way in biotech

Although regarded as a booming industry, the number of women recruits in biotech, let alone in high-ranking positions, is low. Despite progress over the years, a recent report states that only 34% of executive teams and 20% of CEOs are reported to be women in the biotech industry, with even lower figures for women of […]

March 8, 2023 - 11 minutesmins - By Roohi Mariam Peter

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Ampersand Biomedicines launched to develop drugs that only work at disease sites

Beyond Biotech podcast 37: Natural killer cells, biopharma revenue, toxic shock syndrome vaccine

5 advancements in kidney disease research over the past year

Pharma services companies you should know about at Bio-Europe Spring 2023

Research looks to make drug appear like brain tumor ‘food’

Affibody and Chiesi Group to develop treatments for respiratory diseases

Noema Pharma raises $112 million in Series B financing

Could changing mRNA provide a new target for Alzheimer’s disease?

New bone cancer drug could save children’s lives

Should pharma be listening to social media to drive drug development?

How to promote diversity in STEM

5 women leading the way in biotech

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!